MedPath

Pelvic Floor Muscle Training During Pregnancy

Not Applicable
Not yet recruiting
Conditions
Pelvic Floor
Urinary Incontinence
Anal Incontinence
Pelvic Organ Prolapse
Sexual Dysfunction
Registration Number
NCT07104292
Lead Sponsor
University of Southern Denmark
Brief Summary

The project seeks to investigate effectiveness of PFMT during pregnancy.

Detailed Description

First-time pregnant women will be recruited through visitations received from family doctors in all obstetrics departments of the Southern Denmark Region. Women will be randomised into two groups: ( Pelvic Floor Muscle Training) PFMT and a control group (standard care). The motivation-informed intervention will tackle both exercise engagement and exercise adherence. The women will receive an easily accessible, home-based PFMT program electronically in which they will be motivated to start and engage during pregnancy with continuity after birth. The data regarding pelvic floor disorders will be obtained at baseline, follow-ups once every trimester of pregnancy, as well as six weeks, three months, and six months postpartum with further follow-up after the study. The data regarding obstetric outcomes will be collected from electronic patient records. For evaluation of implementation process, data regarding motivation and training acceptability will be obtained via questionnaire at the baseline and at follow-up together with telephonically interviews during pregnancy and postpartum.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
734
Inclusion Criteria
  • Woman in the 1st trimester of pregnancy (up to 12+6 weeks of gestation)
  • Para 0 (no previous birth or pregnancy > 16 weeks of gestation)
  • Understands, writes, and reads fluently in Danish or English
  • Has a smart phone or computer/tablet to reach the training program
Exclusion Criteria
  • Severe psychiatric illness (e.g. schizophrenia, bipolar disorder, severe depression or anxiety)
  • Active substance abuse
  • Acute social crises (e.g. homelessness, ongoing domestic violence, severe financial instability, lack of social support)
  • Women with limited capacity to provide informed consent (due to cognitive impairment or language barriers)
  • Previous pregnancy of > 16 weeks of gestation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Urinary incontinence (UI) incidence at 3 months postpartumAt 3 months follow-up after giving birth

International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score between 0 (perfect continence) and 21 (total incontinence).

Secondary Outcome Measures
NameTimeMethod
Urinary incontinence at the 1st trimester of pregnancyAt baseline, during the 1st trimester of pregnancy (gestational age (GA) up to 12 weeks +6 days)

ICIQ-UI SF score between 0-21

Urinary incontinence at the 2nd trimester of pregnancyAt the follow-up at Gestational age 26 weeks and 0 days

ICIQ-UI SF score between 0-21

Urinary incontinence incidence at the 3rd trimester of pregnancyAt the follow-up at Gestational Age 36 weeks and 0 days

ICIQ-UI SF score between 0-21

Urinary incontinence incidence at 6 weeks postpartumAt the follow-up at 6 weeks postpartum

ICIQ-UI SF score between 0-21

Anal incontinence (AI) incidence at inclusion, during the 1st trimester of pregnancyAt baseline, during the 1st trimester of pregnancy (gestational age (GA) up to 12 weeks +6 days)

Colorectal-anal distress inventory 8 (CRAD-8), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100). Answer yes to one of the three questions about anal incontinence will be considered as AI.

Anal incontinence (AI) in the 2nd trimester of pregnancyAt the follow-up at Gestational Age 26 weeks and 0 days

Colorectal-anal distress inventory 8 (CRAD-8), score 0-100. Answer yes to one of the three questions about anal incontinence will be considered as AI.

Anal incontinence (AI) incidence in the 3rd trimester of pregnancyAt the follow-up at Gestational Age 36 weeks and 0 days

Colorectal-anal distress inventory 8 (CRAD-8), score 0-100. Answer yes to one of the three questions about anal incontinence will be considered as AI.

Anal incontinence (AI) incidence at 6 weeks postpartumAt the follow-up at 6 weeks postpartum

Colorectal-anal distress inventory 8 (CRAD-8), score 0-100. Answer yes to one of the three questions about anal incontinence will be considered as AI.

Anal incontinence (AI) incidence at 3 months postpartumAt the follow-up at 3 months postpartum

Colorectal-anal distress inventory 8 (CRAD-8), score 0-100. Answer yes to one of the three questions about anal incontinence will be considered as AI.

Anal incontinence (AI) incidence at 6 months postpartumAt the follow-up at 6 months postpartum

Colorectal-anal distress inventory 8 (CRAD-8), score 0-100. Answer yes to one of the three questions about anal incontinence will be considered as AI.

Sexual dysfunction incidence at inclusion, during the 1st trimester of pregnancyAt baseline, during the 1st trimester of pregnancy (gestational age (GA) up to 12 weeks +6 days)

Female Sexual Function Index-6 (FSFI-6) score between 2 to 30

Sexual dysfunction incidence at inclusion, during the 2nd trimester of pregnancyAt the follow-up at Gestational Age 26weeks and 0 days

Female Sexual Function Index-6 (FSFI-6) score between 2 to 30

Sexual dysfunction incidence at inclusion, during the 3rd trimester of pregnancyAt the follow-up at Gestational Age 36 weeks and 0 days

Female Sexual Function Index-6 (FSFI-6) score between 2 to 30

Sexual dysfunction incidence at 6 weeks postpartumAt the follow-up at 6 weeks postpartum

Female Sexual Function Index-6 (FSFI-6) score between 2 to 30

Sexual dysfunction incidence at 3 month postpartumAt the follow-up at 3 month postpartum

Female Sexual Function Index-6 (FSFI-6) score between 2 to 30

Sexual dysfunction incidence at 6month postpartumAt the follow-up at 6 month postpartum

Female Sexual Function Index-6 (FSFI-6) score between 2 to 30

Pelvic organ prolapse (POP) incidence at inclusion, during the 1st trimester of pregnancyAt baseline, during the 1st trimester of pregnancy (gestational age (GA) up to 12 weeks and 6 days)

Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100).

Pelvic organ prolapse (POP) incidence, in the 2nd trimester of pregnancyAt the follow-up at gestational age 26 weeks and 0 days

Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100).

Pelvic organ prolapse (POP) incidence, in the 3rd trimester of pregnancyAt the follow-up at gestational age 36 weeks and 0 days

Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100).

Pelvic organ prolapse (POP) incidence at 6 weeks postpartumAt the follow-up at 6 weeks postpartum

Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100).

Pelvic organ prolapse (POP) incidence at 3 months postpartumAt the follow-up at 3 months postpartum

Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100).

Pelvic organ prolapse (POP) incidence at 6 months postpartumAt the follow-up at 6 months postpartum

Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6), a part of Pelvic Floor Disability Index (PFDI-20) questionnaire: score calculated by the mean value of all item scores (possible 0-4) multiplied by 25 to obtain the score (range 0 to 100).

Length of the second stage of deliveryThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum.

Length in minutes (minimum 0 - maximum 300 minutes).

Delivery modeThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum.

Vaginal, planned or unplanned Caesarean.

Foetal positionThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum.

Cephalic regular (occiput anterior), cephalic occiput posterior or breech

EpisiotomyThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum

Yes or no

Perineal tearThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum.

Yes or no; if yes - tear degree (1st, 2nd, 3rd (3a, 3b, 3c), 4th)

Instrumental deliveryThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum.

Yes or no; if yes - type (vacuum assisted or forceps)

Length of the first stage of deliveryThe outcome is registered in electronic patient journal during delivery, but the outcome will be collected during the first 3 months postpartum.

Length in minutes (minimum 0 - no maximum)

Fidelity of PFMTThe questionnaire is filled every week from baseline to 6 months postpartum

Self-reported training frequency (from 0 to 4 times a week)

Other implementation outcomes: acceptability, feasibility, appropriatenessAt study completion

Will be collected through short interviews

Trial Locations

Locations (1)

Sygehus Sønderjylland

🇩🇰

Aabenraa, Southern Denmark, Denmark

Sygehus Sønderjylland
🇩🇰Aabenraa, Southern Denmark, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.